Patents by Inventor Jonathan Alan Murray
Jonathan Alan Murray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10960090Abstract: A general illumination lighting system and/or at least one targeted surface illumination lighting system. The general illumination lighting system including a general illuminating light source configured to generate light toward one or more surfaces or materials to inactivate one or more pathogens on the one or more surfaces or materials. The at least one targeted surface illumination lighting system including one or more targeted surface illuminating light sources that are integrated into or coupled to a plurality of devices, equipment, or fixtures. The one or more targeted surface illuminating light sources configured to generate targeted light toward one or more surfaces of the devices, equipment, or fixtures to inactivate one or more pathogens on the one or more surfaces. The light from the general illuminating light source and the one or more targeted surface illuminating light source including an inactivating portion having wavelengths in a range of 280 to 380 nanometers.Type: GrantFiled: May 25, 2018Date of Patent: March 30, 2021Assignee: CURRENT LIGHTING SOLUTIONS, LLCInventors: Thomas Clynne, Gary Robert Allen, Kevin Jeffrey Benner, Kevin James Vick, Erik Leeming Kvam, Jonathan Alan Murray
-
Patent number: 10578251Abstract: Methods and systems are provided for a sealing system for a dynamic nuclear polarization (DNP) system. In one embodiment, a system comprises: a reservoir including an inlet opening; an outer tube; and a tapered seal shaped to seal against the inlet opening and the outer tube, the tapered seal including: a first section removably coupleable to a second section; a through-hole formed by a first plurality of inner surfaces of both the first section and the second section, the through-hole shaped to encircle the outer tube; and a vacuum channel extending through, from an outer surface to an inner surface of the first plurality of inner surfaces, one of the first section and second section. In this way, the tapered seal may be coupled around the fluid passage without inserting a tip of the fluid passage through the through-hole of the tapered seal, thereby maintaining a sterility of the system.Type: GrantFiled: September 1, 2017Date of Patent: March 3, 2020Assignee: General Electric HealthcareInventors: Ernst Wolfgang Stautner, Jonathan Alan Murray, Patrick Lively Padgett
-
Patent number: 10481222Abstract: A cooling system is provided. The cooling system is associated with a dynamic nuclear polarization system and configured to cool a sample to a temperature suitable for dynamic nuclear polarization to be carried out on the sample while the sample is in the cooling system. The cooling system includes a cryogenic chamber that includes a cryogenic fluid. The cooling system also includes a removable sample sleeve insertable within a portion of the cryogenic chamber. The removable sample sleeve is configured to define a sample path for the sample within the cryogenic chamber that is isolated from other parts of the cooling system.Type: GrantFiled: July 24, 2017Date of Patent: November 19, 2019Assignee: General Electric CompanyInventors: Ernst Wolfgang Stautner, Jan Henrik Ardenkjaer-Larsen, Patrick L. Padgett, Jonathan Alan Murray, Rui Chen, James Richard Trigger, Arnaud Comment, Albert Po-Fu Chen
-
Publication number: 20190025387Abstract: A cooling system is provided. The cooling system is associated with a dynamic nuclear polarization system and configured to cool a sample to a temperature suitable for dynamic nuclear polarization to be carried out on the sample while the sample is in the cooling system. The cooling system includes a cryogenic chamber that includes a cryogenic fluid. The cooling system also includes a removable sample sleeve insertable within a portion of the cryogenic chamber. The removable sample sleeve is configured to define a sample path for the sample within the cryogenic chamber that is isolated from other parts of the cooling system.Type: ApplicationFiled: July 24, 2017Publication date: January 24, 2019Inventors: Ernst Wolfang Stautner, Jan Henrik Ardenkjaer-Larsen, Patrick L. Padgett, Jonathan Alan Murray, Rui Chen, James Richard Trigger, Arnaud Comment, Albert Po-Fu Chen
-
Publication number: 20190003653Abstract: Methods and systems are provided for a sealing system for a dynamic nuclear polarization (DNP) system. In one embodiment, a system comprises: a reservoir including an inlet opening; an outer tube; and a tapered seal shaped to seal against the inlet opening and the outer tube, the tapered seal including: a first section removably coupleable to a second section; a through-hole formed by a first plurality of inner surfaces of both the first section and the second section, the through-hole shaped to encircle the outer tube; and a vacuum channel extending through, from an outer surface to an inner surface of the first plurality of inner surfaces, one of the first section and second section. In this way, the tapered seal may be coupled around the fluid passage without inserting a tip of the fluid passage through the through-hole of the tapered seal, thereby maintaining a sterility of the system.Type: ApplicationFiled: September 1, 2017Publication date: January 3, 2019Inventors: Ernst Wolfgang Stautner, Jonathan Alan Murray, Patrick Lively Padgett
-
Publication number: 20180339073Abstract: A general illumination lighting system and/or at least one targeted surface illumination lighting system. The general illumination lighting system including a general illuminating light source configured to generate light toward one or more surfaces or materials to inactivate one or more pathogens on the one or more surfaces or materials. The at least one targeted surface illumination lighting system including one or more targeted surface illuminating light sources that are integrated into or coupled to a plurality of devices, equipment, or fixtures. The one or more targeted surface illuminating light sources configured to generate targeted light toward one or more surfaces of the devices, equipment, or fixtures to inactivate one or more pathogens on the one or more surfaces. The light from the general illuminating light source and the one or more targeted surface illuminating light source including an inactivating portion having wavelengths in a range of 280 to 380 nanometers.Type: ApplicationFiled: May 25, 2018Publication date: November 29, 2018Inventors: Thomas CLYNNE, Gary Robert ALLEN, Kevin Jeffrey BENNER, Kevin James VICK, Erik Leeming KVAM, Jonathan Alan MURRAY
-
Patent number: 9874622Abstract: A system and method for transporting a hyperpolarized substance is disclosed. A transport vessel for transporting such a hyperpolarized substance includes a vessel housing, a chamber formed within the vessel housing that is configured to receive a container holding a hyperpolarized substance, and an electromagnet configured to generate a magnetic containment field about the chamber when a current is supplied thereto, the magnetic containment field comprising a homogeneous magnetic field. The transport vessel also includes a non-magnetic power source to supply the current to the electromagnet and a control circuit configured to selectively interrupt the supply of current to the electromagnet so as to control generation of the magnetic containment field, with the transport vessel being magnetically inert when the supply of current to the electromagnet is interrupted by the control circuit.Type: GrantFiled: September 27, 2013Date of Patent: January 23, 2018Assignee: General Electric CompanyInventors: Timothy William Skloss, Jonathan Alan Murray, Jan Henrik Ardenkjaer-Larsen, Murali K. Cherukuri, Marcelino Bernardo, Nallathamby Devasahayam
-
Publication number: 20150091573Abstract: A system and method for transporting a hyperpolarized substance is disclosed. A transport vessel for transporting such a hyperpolarized substance includes a vessel housing, a chamber formed within the vessel housing that is configured to receive a container holding a hyperpolarized substance, and an electromagnet configured to generate a magnetic containment field about the chamber when a current is supplied thereto, the magnetic containment field comprising a homogeneous magnetic field. The transport vessel also includes a non-magnetic power source to supply the current to the electromagnet and a control circuit configured to selectively interrupt the supply of current to the electromagnet so as to control generation of the magnetic containment field, with the transport vessel being magnetically inert when the supply of current to the electromagnet is interrupted by the control circuit.Type: ApplicationFiled: September 27, 2013Publication date: April 2, 2015Applicants: General Electric Company, The United States of America, As Represented By The Secretary, Department of Health and Human ServInventors: Timothy William Skloss, Jonathan Alan Murray, Jan Henrik Ardenkjaer-Larsen, Murali K. Cherukuri, Marcelino Bernardo, Nallathamby Devasahayam
-
Publication number: 20110270073Abstract: An electron paramagnetic resonance imaging (EPRI) system includes a resistive magnet driven by a power supply such as a power supply module to generate radio frequency signals in a substantially coherent polyphase perfect sequence scheme. The EPRI system further includes image acquisition and processing electronics configured to generate, acquire, quantify and map pO2 information associated with a free radical agent in vivo and having a resonance line width that is sensitive to oxygen and in response to the radio frequency signals without imparting harmful heating effects to a corresponding human or animal body.Type: ApplicationFiled: April 29, 2010Publication date: November 3, 2011Applicant: GENERAL ELECTRIC COMPANYInventors: Jan-Henrik Ardenkjaer-Larsen, Jonathan Alan Murray, Fraser John Laing Robb, Ralph Eugene Hurd, Victor Taracila
-
Patent number: 6507753Abstract: In order to reduce bias associated with conventional ECG analysis, the present invention provides a method and apparatus to improve diagnosis of acute cardiac syndromes (ACS), such as acute myocardial infarction and acute cardiac ischemia (unstable angina), in specified groups of patients using ECG signals and automatic detection analysis. Specific criteria are developed and utilized based on a prespecified group selection for the particular patient. After identifying group membership for the particular patient, ECG data are acquired from a patient experiencing ACS symptoms. Known criteria typically used for assessing ACS are then modified for the particular group membership. Such criteria significantly reduce the bias found in a baseline group for which the known criteria were established.Type: GrantFiled: August 9, 2000Date of Patent: January 14, 2003Assignee: GE Marquette Medical Systems, Inc.Inventors: Qiuzhen Xue, Shankara Bonthu Reddy, Basel Taha, Jonathan Alan Murray